Finzati - Logo
BYSI logo

BeyondSpring Inc.

BYSI • Biotechnology
$0.52
▲ +0.01 (+1.91%)
Current price
EarningsLatest report: Jun 30, 2026
WEAK PROFILEWeakConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$34.50M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Healthy liquidity · 1.54Negative growth trendWeak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 16, 2026, 12:13 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$0.52
Change1.91%
Market Cap$34.50M
52W Range0.73 - 2.44
Beta0.43
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq-0.01
Current Ratio1.54
Quick Ratio1.54
Volume769.49K

Investment DNA

How strong this company looks for long-term investors

33
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
65/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
50/100
Why this score▼
Healthy liquidity · 1.54Negative growth trendWeak profitability
Analyst view
No analyst data available now.

Company Overview

IPO: 3/9/2017
Industry: Biotechnology
P/B i: -2.05
Debt / Equity i: -0.01
Operating Margin: 0.00%
Net Margin: 0.00%
ROE i: -
ROIC: -

Financial Health

Score13 / 20
Debt / Equity: -0.01
Current Ratio: 1.54
Quick Ratio: 1.54
Status: Good

Insider Transactions

Recent executive and insider activity

⚠ 2 high-volume insider sells detected
Li Na (NL)
Transaction: 07/01/2026
OTHER
Change
0
Price
Not reported
Filing
07/06/2026
Type
OTHER
Qiu Min
Transaction: 07/01/2026
OTHER
Change
0
Price
Not reported
Filing
07/06/2026
Type
OTHER
Qiu Min
Transaction: 07/01/2026
BUY
Change
+100,000
Price
$1.75
Filing
07/06/2026
Type
BUY